References
- Colvin RB, Fuller TC, Mackeen L, Kung PC, Ip SH, Cosimi AB. Plasma interleukin 2 receptor levels in renal allograft recipients. Clin Immunol Immunopathol 1987; 43: 273–6.
- Takamatsu T, Yasuda N, Ohno T, Kanoh T, Uchino H, Fujisawa A. Soluble interleukin-2 receptors in the serum of patients with chronic renal failure. Tohoku J Exp Med 1988; 155: 343–7.
- Yorioka N, Hirabayashi A, Takemasa A, Kanahara K, Takahashi N, Oda H, et al. Serum soluble interleukin 2 receptor in patients with IgA nephropathy. Hiroshima J Med Sci 1989; 38: 169–71.
- Beaurain G, Naret C, Marcon L, Grateau G, Drueke T, Urena P, et al. In vivo T cell preactivation in chronic uremic hemodialyzed and non-hemodialyzed patients. Kidney Int 1989; 36: 636–44.
- Yorioka N, Hirabayashi A, Kanahara K, Takemasa A, Oda H, Joarder ZH, et al. Serum soluble interleukin-2 receptor in patients with glomerulonephritis. Am J Nephrol 1990; 10: 181–5.
- Yorioka N, Ogawa T, Kanahara K, Oda H, Hamaguchi N, Takasugi N, et al. Serum soluble interleukin 2 receptor in maintenance hemodialysis patients. J Jap Soc Dial Ther 1990; 23: 319–22 (in Japanese).
- Walz G, Kunzendorf U, Josimovic-Alasevic 0, Preusch-off L, Schwarz A, Keller F, et al. Soluble interleukin 2 receptor and tissue polypeptide antigen serum concen-trations in end-stage renal failure. Nephron 1990; 56: 157–61.
- Donati D, Degiannis D, Homer L, Gastaldi L, Raskova J, Raska Jr K. Immune deficiency in uremia: interleukin-2 production and responsiveness and interleukin-2 receptor expression and release. Nephron 1991; 58: 268–75.
- Hory B, Racadot E, Saint-Hillier Y, Peters A, Perol C. Soluble interleukin-2 receptors in chronic renal failure. Am J Nephrol 1991; 11: 276–80.
- Descamps-Latscha B, Herbelin A, Nguyen AT, Roux-Lombard P, ZingraffJ, Moynot A, et al. Balance between IL-113, TNF-a, and their specific inhibitors in chronic renal failure and maintenance dialysis. Relationships with activation markers of T cells, B cells, and monocytes. J Immunol 1995; 154: 882–92.
- Chen HS, Wu MS, Chen WY, Lee SH, Yang CS. Serum soluble interleukin-2 receptor in patients with end-stage renal disease on hemodialysis. Dial Transplant 1995; 24: 459–77.
- Chatenoud L, Dugas B, Beaurain G, Touam M, Drueke T, Vasquez A, et al. Presence of preactivated T cells in hemodialyzed patients: their possible role in altered immunity. Proc Natl Acad Sci USA 1986; 83: 7457–61.
- Zaoui P, Green W, Hakim RM. Hemodialysis with cuprophane membrane modulates interleukin-2 receptor expression. Kidney Int 1991; 39: 1020–6.
- Rubin LA, Kurman CC, Fritz ME, Biddison WE, Boutin B, Yarchoan R, et al. Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro. J Immunol 1985; 135: 3172–7.
- Huang YP, Perrin LH, Miescher PA, Zubler RH. Correlation of T and B cell activities in vitro and serum IL-2 levels in systemic lupus erythematosus. J Immunol 1988; 141: 827–33.
- Symons JA, Wood NC, Di Giovine FS, Duff GW. Soluble IL-2 receptor in rheumatoid arthritis. Correlation with disease activity, IL-1 and IL-2 inhibition. J Immunol 1988; 141: 2612–8.
- Semenzato G, Foa R, Agostini C, Zambello R, Trentin L, Vinante F, et al. High serum levels of soluble interleukin 2 receptor in patients with B chronic lymphocytic leukemia. Blood 1987; 70: 396–400.
- Yasuda N, Lai PK, Ip SH, Kung PC, Hinuma Y, Matsuoka M, et al. Soluble interleukin 2 receptors in sera of Japanese patients with adult T cell leukemia mark activity of disease. Blood 1988; 71: 1021–6.
- Rubin LA, Jay G, Nelson DL. The released interleukin 2 receptor binds interleukin 2 efficiently. J Immunol 1986; 137: 3841–4.
- Jacques Y, Le Mauff B, Boeffard F, Godard A, Soulillou JP. A soluble interleukin 2 receptor produced by a normal alloreactive human T cell clone binds interleukin 2 with low affinity. J Immunol 1987; 139: 2308–16.
- Walz G, Kunzendorf U, Haller H, Keller F, Offermann G, Josimovic-Alasevic 0, et al. Factors influencing the response to hepatitis B vaccination of hemodialysis patients. Nephron 1989; 51: 474–7.